Li Yumin, Guo Dongyue, Zhang Bing, Wu Wei, Cai Yanyan, Zhang Xiuming
Medical Laboratory, Shenzhen Luohu Hospital Group, Shenzhen 518001, Guangdong, China. Corresponding author: Zhang Xiuming, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Apr;35(4):427-430. doi: 10.3760/cma.j.cn121430-20230107-01130.
To track analysis of viral nucleic acid test results in patients with re-positive SARS-CoV-2 infection, and provide clinical reference for nucleic acid test of re-positive cases.
A retrospective study was conducted. The multiple nucleic acid results of 96 cases with SARS-CoV-2 infection tested by medical laboratory of Shenzhen Luohu Hospital Group from January to September in 2022 were analyzed. The test dates and cycle threshold (Ct) values of detectable positive virus nucleic acid in the 96 cases were summarized and analyzed.
A total of 96 patients with SARS-CoV-2 infection were retested re-sampled for nucleic acid testing at least 12 days after the initial positive screening. Among them, 54 cases (56.25%) had Ct value of < 35 for nucleocapsid protein gene (N) and/or open reading frame 1ab gene (ORF 1ab), 42 cases (43.75%) had Ct value ≥ 35. In the re-sampling of infected patients, N gene titers were 25.08 to 39.98 Ct cycles, and ORF 1ab gene titers were 23.16 to 39.56 Ct cycles. Compared with the positive results of the initial screening, the Ct values of N gene and/or ORF 1ab gene positive were increased in 90 cases (93.75%). Among them, the patients with the longest duration of nucleic acid positive could still be positive for double targets (the Ct value of N gene was 38.60, and the Ct value of ORF 1ab gene was 38.11) at an interval of 178 days after the initial positive screening.
Patients infected with SARS-CoV-2 can be sustained or repeatedly tested positive for nucleic acid for a long period of time, and most of them had Ct values < 35. But whether it is infectious needs to be comprehensively evaluated by combining epidemiology, variant type, samples with the alive virus, and clinical symptoms and signs.
对新型冠状病毒(SARS-CoV-2)感染复阳患者的病毒核酸检测结果进行追踪分析,为复阳病例核酸检测提供临床参考。
进行回顾性研究。分析2022年1月至9月深圳罗湖医院集团医学检验实验室检测的96例SARS-CoV-2感染患者的多次核酸结果。总结并分析这96例患者可检测到阳性病毒核酸的检测日期及循环阈值(Ct)值。
96例SARS-CoV-2感染患者在初次阳性筛查至少12天后进行了核酸复测及重新采样。其中,54例(56.25%)核衣壳蛋白基因(N)和/或开放阅读框1ab基因(ORF 1ab)的Ct值<35,42例(43.75%)Ct值≥35。在感染患者的重新采样中,N基因滴度为25.08至39.98 Ct周期,ORF 1ab基因滴度为23.16至39.56 Ct周期。与初次筛查阳性结果相比,90例(93.75%)N基因和/或ORF 1ab基因阳性的Ct值升高。其中,核酸阳性持续时间最长的患者在初次阳性筛查178天后仍可双靶点阳性(N基因Ct值为38.60,ORF 1ab基因Ct值为38.11)。
SARS-CoV-2感染患者核酸可长期持续或反复检测呈阳性,且多数Ct值<35。但其是否具有传染性需结合流行病学、变异类型、活病毒样本及临床症状体征综合评估。